Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M
Department of Biochemistry, University of Tsukuba, Japan.
Cancer Res. 1994 Jan 1;54(1):33-5.
A series of 57 mucinous and 47 serous ovarian tumors (adenomas, tumors of borderline malignancy, and carcinomas) were examined by polymerase chain reaction-single strand conformation polymorphism analysis and direct sequencing for mutations in codons 12, 13, and 61 of K-ras gene. Higher incidence of K-ras mutations was observed in mucinous tumors compared to serous ones. Mutations were detected in 4 of 30 mucinous adenomas (13%), in 4 of 12 mucinous tumors of borderline malignancy (33%), and in 7 of 15 mucinous carcinomas (46%). Only 1 of 17 serous carcinomas (6%) had a mutation of K-ras in serous ovarian tumors. All mutations identified were in codon 12. Detailed analysis revealed that more K-ras mutations in mucinous adenomas were observed in intestinal type (identified in 4 of 13) than in endocervical type (identified in 0 of 17). Thus, K-ras gene codon 12 mutations in mucinous ovarian adenomas appear to be associated with the occurrence of intestinal type adenomas.
采用聚合酶链反应-单链构象多态性分析及直接测序法,对57例黏液性和47例浆液性卵巢肿瘤(腺瘤、交界性肿瘤及癌)进行K-ras基因第12、13和61密码子突变检测。结果显示,黏液性肿瘤中K-ras基因突变发生率高于浆液性肿瘤。在30例黏液性腺瘤中有4例(13%)检测到突变,12例黏液性交界性肿瘤中有4例(33%),15例黏液性癌中有7例(46%)。浆液性卵巢肿瘤中,17例浆液性癌仅1例(6%)发生K-ras突变。所有鉴定出的突变均位于第12密码子。详细分析表明,黏液性腺瘤中肠型(13例中有4例)的K-ras突变多于宫颈内膜型(17例中未发现)。因此,黏液性卵巢腺瘤中K-ras基因第12密码子突变似乎与肠型腺瘤的发生有关。